New study aims to sharpen brain tumor tracking with PET imaging

NCT ID NCT07159607

Recruiting now Knowledge-focused Sponsor: LMU Klinikum Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times

Summary

This study observes 100 adults with IDH-mutant gliomas (a type of brain tumor) to see if PET scans can better tell apart tumor growth from treatment side effects compared to standard MRI. Participants will have routine PET imaging alongside their usual care. The goal is to improve how doctors monitor these tumors, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDH-MUTANT GLIOMA (OLIGODENDROGLIOMA, ASTROCYTOMA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

LMU Hospital
RECRUITING

Munich, Bavaria, 81377, Germany

Contact Phone: •••-•••-•••• Email: •••••@•••••
Medical University of Vienna
RECRUITING

Vienna, 1090, Austria

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

IDH-MUTANT GLIOMA (OLIGODENDROGLIOMA, ASTROCYTOMA) IDH-MUTANT GLIOMA (OLIGODENDROGLIOMA, ASTROCYTOMA)